Fundraising Fox
🦊/People
Sign in

Gregory Harriman

Investor

Partner at BioAdvance · Leadership (MD) at Optimeos

Pennsylvania

Writes $1.5M – $5M checks · typically $3.3M

Find your path to Gregory

328 people in our graph share verified history with Gregory — schools, employers, funds. One of them is your warm intro.

Teresa ChanunlockedGregory: together at Johnson & Johnson (2002–2004)
×2Gregory: together at UC San Diego
×6Gregory: together at Johnson & Johnson
Gregory: together at Baylor College of Medicine

About

Physician-scientist and biomedical executive with 25+ years in academic medicine and the biopharma industry, having led drug and biologics development. Founded Main Line Ventures and sits on several BioAdvance portfolio boards.

Contact· self-published, not guessed

Invests in

Biotech

Leadership (MD) at Optimeos

Intro paths

→

In turn, Gregory can intro founders to Optimeos's investors below.

Optimeos's investors · 5

7G BioVenturesBurlingameAnzu PartnersBillericaHatch BioFundDoylestown · since 2026National Institutes of Health (NIH)since 2021National Science FoundationAlexandria · since 2019

Co-founders at Optimeos

RK
Robert K. Prud'homme, PhDDirector
BPBob Prud'homme
Bob Prud'hommeLeadership (PhD)
RPRob Pagels
Rob PagelsLeadership (PhD)
CMChet Markwalter
Chet MarkwalterLeadership (PhD)

Experience

  1. Optimeos Life SciencesChief Medical Officercurrent2022 — presentUnited States
  2. BioAdvance CapitalPartner, Chief Investment Officercurrent2021 — presentRadnor, Pennsylvania, United States
  3. Main Line VenturesPresidentcurrent2006 — present
  4. Senzo HealthDirectorcurrent2022 — present
  5. Opsidio, LLCDirectorcurrent2017 — present
  6. TreventisDirectorcurrent2012 — present
  7. BioAdvanceVenture Partner2012 — 2021Radnor, PA
  8. RIBONOVA INC.Director2016 — 2021
  9. Genome Profiling, LLCDirector2017 — 2018
  10. Robin Hood VenturesMember2010 — 2017
  11. ImmunomeDirector2012 — 2017
  12. Enzium, Inc.Director2015 — 2017
  13. QR PharmaDirector2012 — 2014
  14. Drexel UniversityResearch Professor, School of Biomedical Engineering, Science and Health Systems2010 — 2014
  15. Novira TherapeuticsDirector2011 — 2012Radnor, PA
  16. Johnson & JohnsonVice President2001 — 2009
  17. CentocorExecutive Director1998 — 2001
  18. IVAXMedical Director1996 — 1998
  19. Baylor College of MedicineAssistant Professor of Medicine1991 — 1996Houston, Texas

Skills & more

Angel Investing3Business Development9Lifesciences21Biotechnology29Commercialization14Venture Capital16Medical Devices13Clinical Development9Technology Transfer7Healthcare4Start-ups23Immunology7
+12 moreOncologyEntrepreneurshipDrug DevelopmentHardware DiagnosticsDrug DiscoveryScienceClinical TrialsInfectious DiseasesStrategic PlanningPharmaceutical IndustryBiomedical EngineeringBiopharmaceuticals

From Gregory's professional profile.

Investments

Board seats

AnnovisGenProImmunomeNoviraOpsidioRibonovaTreventis

Investor

OpsidioSenzo

Sources: the firm's website · curated public sources.

Colleagues at BioAdvance

Adam Glasofer
Entrepreneur-in-Residence at BioAdvance
David Shin
Partner at BioAdvance
Frederick Jones
Advisory Partner at BioAdvance
Gayle Mineo
Office Management at BioAdvance
Jeff Edelson
Entrepreneur-in-Residence at BioAdvance
Jen Gilburg
Board of Directors; Deputy Secretary, Office of Technology & Entrepreneurship, PA DCED at BioAdvance
Jonathan Epstein
Board of Directors; Dean of the School of Medicine and EVP of the Health System, University of Pennsylvania at BioAdvance
Marie Lindner
Entrepreneur-in-Residence at BioAdvance

Frequently asked questions

Who is Gregory Harriman?
Physician-scientist and biomedical executive with 25+ years in academic medicine and the biopharma industry, having led drug and biologics development. Founded Main Line Ventures and sits on several BioAdvance portfolio boards.
Where does Gregory Harriman work?
Gregory Harriman is Partner at BioAdvance and Leadership (MD) at Optimeos.
What does Gregory Harriman invest in?
Gregory Harriman invests in Biotech.
What check size does Gregory Harriman write?
Gregory Harriman typically writes checks of $1.5M – $5M.
What boards does Gregory Harriman sit on?
Gregory Harriman holds tracked board seats at Annovis, GenPro, Immunome, Novira, Opsidio, Ribonova, Treventis.
What companies has Gregory Harriman invested in?
Investments tracked here include Opsidio, Senzo.
Where did Gregory Harriman go to school?
Gregory Harriman studied at UC San Diego (M.D., Medicine); University of California, Berkeley.

Same school

Shared employers